MENU
CYDY
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

CytoDyn (CYDY) Ownership - Who owns CytoDyn?

CytoDyn Inc is a USA-based clinical-stage biotechnology company that focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection... Show more

Profile

Industry
N/A
Address
1111 Main Street
Phone
+1 360 980-8524
Employees
12
Web
https://www.cytodyn.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
475.82M
P/E Ratio
N/A
Total Cash
15.66M
Projected Growth
N/A
Total Debt
27.23M
Revenue
N/A
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
CYDY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1111 Main Street
Phone
+1 360 980-8524
Employees
12
Web
https://www.cytodyn.com